Home › Launch Delays The Wrong Prescription For GenMark Shares
 

Keywords :   


Launch Delays The Wrong Prescription For GenMark Shares

2015-10-06 22:39:33| Biotech - Topix.net

Every market day, we select up to 20 of our authors' top long and short ideas, exclusively for PRO subscribers. A commercialization delay announced back in April has kept GenMark in the market's penalty box while rival BioMerieux has continued to see strong FilmArray adoption and use.

Tags: wrong shares launch prescription

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.05Eastern North Pacific Tropical Weather Outlook
22.05Atlantic Tropical Weather Outlook
22.05UK watchdog looking into Microsoft AI taking screenshots
21.05Clarins Begins Testing Generative AI-powered Customer Care Bot in US
21.05Waldencast Reports $68.3 Million in Net Revenue in Q1 2024
21.05Pixalate releases April 2024 top grossing CTV apps report
21.05A+E Networks EMEA enhances BLAZE streaming service with Simplestream
21.05Minerva unveils FAST+ Service for operators in North America
More »